Therapy Areas: Inflammatory Diseases
25 March 2024 - AI-enabled drug discovery and development company BenevolentAI (Euronext Amsterdam:BAI) on Monday reported positive safety data from the Phase Ia clinical trial of BEN-8744 in healthy ...
8 March 2024 - Biotechnology company Thermo Fisher Scientific Inc. (NYSE:TMO) has unveiled its latest CorEvitas syndicated clinical registry for Generalized Pustular Psoriasis (GPP), addressing the ne...
6 March 2024 - US biotechnology company Nektar Therapeutics (Nasdaq:NKTR) announced on Tuesday the start of its Phase 2b clinical trial evaluating rezpegaldesleukin (REZPEG) in patients with severe to...
1 March 2024 - LISCure Biosciences, a South Korea-based clinical-stage biopharmaceutical company, announced on Thursday that it has received approval for its Investigational New Drug (IND) application...
1 March 2024 - Innovent Biologics, Inc. (HKEX: 01801), a China-based biopharmaceutical company, announced on Thursday that it has dosed its first participant in a first-in-human (FIH) phase one clinic...
28 February 2024 - Ananda Developments (AQSE: ANA), a provider of cannabinoid-based medicines for complex, chronic inflammatory pain conditions, announced on Wednesday that through its subsidiary MRX ...